FreeStyle Libre Portfolio

Make glucose monitoring easy

The FreeStyle Libre Portfolio exists to empower those living with diabetes to make diabetes self-management choices and to help you, as their healthcare professional, to support them in their journey. We have the #1 sensor-based glucose monitoring system which is used worldwide3.

 

FreeStyle Libre Systems

Our FreeStyle Libre product range includes two different generations of sensor. 

The #1 sensor-based glucose monitoring system used worldwide3.

 

FreeStyle Libre 3 System

Next-gen CGM performance you can count on with the worlds smallest, thinnest1, and most discreet2 sensor.

FreeStyle Libre 3 System shown on a smartphone.
FreeStyle Libre 3 System shown on a smartphone.
FreeStyle Libre 3 System shown on a smartphone.

FreeStyle Libre 2 System

Our sensor-based glucose monitoring system with optional alarms. Excellent accuracy – no finger pricks.4,†

FreeStyle Libre 2 System shown on a smartphone.
FreeStyle Libre 2 System shown on a smartphone.
FreeStyle Libre 2 System shown on a smartphone.

References & Disclaimers

Images are for illustrative purposes only. Not real patient or data.

The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app.Use of FreeStyle LibreLink requires registration with LibreView.

The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.

1. Among patient-applied sensors.

2. Data on file, Abbott Diabetes Care, Inc.

3. Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use sensor based glucose monitoring systems.

4. Alva, Shridhara, Timothy Bailey, Ronald L. Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System with Advanced Algorithm in Pediatric and Adult Population With Diabetes. Journal of Diabetes Science and Technology, (September 2020).http://doi.org/10.1177/1932296820958754.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

Loading...